相关实验视频
Updated: Jan 17, 2026

10:40
CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
2.8K
XRCC1-Arg399Gln多态和前列腺癌风险之间的关联:更新的元分析
Jiang Deng1, Lihua Xu2, Jun Zhou3
1Hubei No. 3 People's Hospital of Jianghan University, Wuhan, China. 15972096274@163.com.
Amino acids
|September 17, 2025
概括
XRCC1基因多态 (Arg399Gln) 与前列腺癌风险有关. 这次元分析发现了显著的关联,特别是在亚洲人群中,这表明它可能作为预后生物标志物.
科学领域:
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 受到XRCC1基因多态性等遗传变异影响的DNA修复能力在癌症发展中至关重要.
- 缺陷的DNA修复与各种癌症有关,包括前列腺癌 (PCa).
- 之前关于XRCC1编码子399多态和PCa风险之间的关联的研究已经产生了不确定的结果.
研究的目的:
- 进行更新的元分析,以澄清XRCC1 Arg399Gln多态和前列腺癌风险之间的关联.
- 评估这种多形态的潜力作为PCa风险和预后的生物标志物.
主要方法:
- 在PubMed,EMBASE,Wanfang,CNKI和Web of Science数据库中进行了系统的文献搜索.
- 二十个病例控制研究包括5803个PCa病例和5470个对照被纳入了元分析.
- 使用Stata软件计算95%置信区间 (CI) 的原始赔率比率 (OR),以评估相关性.
主要成果:
- 分析显示,XRCC1 Arg399Gln多态性与前列腺癌风险增加之间存在显著的关联.
- 具体来说,在衰退模型下,多态性与亚洲人群中PCa的明显更高的患病率有关 (OR=1.255,95%CI=1.063-1.481).
- 观察到的异质性很低 (I2 <25%).
结论:
- XRCC1 Arg399Gln 多态性是前列腺癌的潜在危险因素.
- 这种遗传变异可能成为预测前列腺癌预后的宝贵生物标志物.
相关概念视频
Genome-wide Association Studies-GWAS
15.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.3K
Single Nucleotide Polymorphisms-SNPs
17.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.9K

